426 related articles for article (PubMed ID: 29521252)
21. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
[TBL] [Abstract][Full Text] [Related]
23. Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents.
Sri Ramya PV; Guntuku L; Angapelly S; Karri S; Digwal CS; Babu BN; Naidu VGM; Kamal A
Bioorg Med Chem Lett; 2018 Mar; 28(5):892-898. PubMed ID: 29429834
[TBL] [Abstract][Full Text] [Related]
24. Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and
Alqahtani AS; Ghorab MM; Nasr FA; Ahmed MZ; Al-Mishari AA; Attia SM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):86-99. PubMed ID: 34894963
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
Buduma K; Chinde S; Dommati AK; Sharma P; Shukla A; Srinivas KVNS; Arigari NK; Khan F; Tiwari AK; Grover P; Jonnala KK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1633-1638. PubMed ID: 26873414
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pro-apoptotic effects of new sulfonamide derivatives via activating p38/ERK phosphorylation in cancer cells.
Cumaoglu A; Dayan S; Agkaya AO; Ozkul Z; Ozpozan NK
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):413-9. PubMed ID: 25198886
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P
Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of neocryptolepines and carbocycle-fused quinolines and evaluation of their anticancer and antiplasmodial activities.
Akkachairin B; Rodphon W; Reamtong O; Mungthin M; Tummatorn J; Thongsornkleeb C; Ruchirawat S
Bioorg Chem; 2020 May; 98():103732. PubMed ID: 32171989
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V
Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of tetrahydroquinolin-2(1H)-one derivatives as novel anti-pancreatic cancer agents via targeting autophagy.
Shen Q; Wang J; Liu CX; Cui W; Zhang L; Zhang YC; Wang Y; Wu J; Li JX
Eur J Med Chem; 2019 May; 170():28-44. PubMed ID: 30878830
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents.
Su T; Zhu J; Sun R; Zhang H; Huang Q; Zhang X; Du R; Qiu L; Cao R
Eur J Med Chem; 2019 Sep; 178():154-167. PubMed ID: 31181480
[TBL] [Abstract][Full Text] [Related]
34. Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent.
Mittal RK; Purohit P
Anticancer Agents Med Chem; 2020; 20(16):1981-1991. PubMed ID: 32560612
[TBL] [Abstract][Full Text] [Related]
35. Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents.
Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Ghorab MM; Noaman E
Eur J Med Chem; 2010 May; 45(5):1849-53. PubMed ID: 20149941
[TBL] [Abstract][Full Text] [Related]
36. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
38. Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors.
Ghorab MM; Alsaid MS; Nissan YM; Ashour AE; Al-Mishari AA; Kumar A; Ahmed SF
Chem Pharm Bull (Tokyo); 2016; 64(12):1747-1754. PubMed ID: 27904083
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5-Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan-1).
Asghar S; Hameed S; Al-Masoudi NA; Saeed B; Shtaiwi A
Chem Biodivers; 2024 May; 21(5):e202400112. PubMed ID: 38606640
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Evaluation of Some Dibromoquinazoline-sulphonamide Hybrids and some Schiff´s Base Analogs for their Cytotoxic Activity.
Ahmed MF; El-Haggar R
Anticancer Agents Med Chem; 2017 Nov; 17(11):1563-1569. PubMed ID: 28356022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
